Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Trial to Evaluate the Safety and Immunogenicity of Monovalent H5N1 Vaccine in Adults >=18 Yrs of Age

NCT00719043 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00719043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00719043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Trial to Evaluate the Safety and Immunogenicity of Monovalent H5N1 Vaccine in Adults >=18 Yrs of Age
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
July 11, 2008
Completion date
February 18, 2011
Enrollment
841 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

influenza